Events Archives - Page 71 of 287

WednesdayMay 29, 2019 10:10 am

INmune Bio Inc. (NASDAQ: INMB) is “One to Watch”

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation as a cause of Alzheimer’s disease Receiver of “Part the Cloud” $1 million grant awarded by Alzheimer’s Association Experienced leadership with extensive experience in the targeted fields of clinical research and drug development Intellectual property with multiple filings in process for INB03/XPro1595 and INKmune Insider…

WednesdayMay 29, 2019 9:00 am

Biotechs That Successfully Combat Cancer Could See Blockbuster Returns

NetworkNewsWire Editorial Coverage: Gene therapy is hot on the trail of killing cancer, and companies that deliver cures could see blockbuster returns. Pioneering a new paradigm in cancer therapeutics, Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is leveraging its patented technology platform to deliver powerful tumor-suppressing genes directly into cancer cells. Calithera Biosciences Inc. (NASDAQ: CALA) is looking for cures for cancer and other life-threatening diseases by discovering, developing and commercializing novel, small-molecule drugs that target tumor and immune cell metabolism. Adaptimmune Therapeutics plc (NASDAQ: ADAP) is developing novel cancer immunotherapy products for cancer patients by engineering T-cells to target and destroy cancer. Agenus…

TuesdayMay 28, 2019 12:10 pm

Genprex Inc. (NASDAQ: GNPX) Pioneering an Innovative Cancer Therapy, Preclinical Data Shows Positive Results

Gene therapy could help overcome barriers that currently stand in the way of a cure for cancer Genprex is developing innovative, gene-based approaches toward the treatment of cancer, specifically non-small cell lung cancer Clinical trials so far have yielded encouraging data regarding the efficacy and safety of the company’s product candidate, Oncoprex Gene therapy could potentially advance the creation and delivery of effective cancer treatments in the years to come. Various companies are leading the way, and pioneers such as Genprex Inc. (NASDAQ: GNPX) are pushing for the introduction of innovative and targeted therapies that have the potential to help…

FridayMay 24, 2019 11:29 am

HODL RALLY to Take Over W Hotel in Barcelona for Barcelona Blockchain Summit

Come along for the ride as HODL RALLY heads to Barcelona to take over the W Hotel for the EVOLV Blockchain Summit. The two-day conference, planned for July 4-5, will feature experts and developers in the crypto and blockchain spaces for a series of addresses and panel discussions. The event will also encompass several entertaining functions, as well as roundtable discussions with industry influencers and leaders, all against the backdrop of the beautiful Mediterranean Sea. The Barcelona Blockchain Summit will be the pièce de résistance of HODL RALLY, which will soon be winding its way across Europe to promote blockchain…

FridayMay 24, 2019 11:09 am

B. Riley FBR Investor Conference Offered a Snapshot of the Mid-Market Investment Landscape

At the B. Riley FBR 20th Annual Institutional Investor Conference, B. Riley FBR offered another unique opportunity to see the areas of investment on which mid-market companies are currently focused. Taking place May 22-23 at The Beverly Hilton in Beverly Hills, California, the widely anticipated event hosted approximately 300 noteworthy public and private companies operating across a diverse array of industries. For the more than 1,200 institutional investors, corporate clients and high net-worth individuals who attended, the event offered a unique snapshot of the current investor landscape. Assembled by the award-winning research analysts at B. Riley FBR, presenting companies were selected from disparate…

ThursdayMay 23, 2019 6:30 pm

Second Sight Medical Products Inc. (EYES) Starts Presentation at B. Riley Conference

Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics intended to deliver useful artificial vision to blind individuals. A global leader in neuromodulation devices for blindness, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus® II Retinal Prosthesis System is the only FDA and CE Mark approved device for treating retinitis pigmentosa, with proven implant durability of multiple years. The company is developing the Orion® Visual Cortical Prosthesis which is intended to provide useful artificial vision to individuals who are blind due to various causes. For…

ThursdayMay 23, 2019 6:30 pm

Select Energy Services Inc. (WTTR) Starts Presentation at B. Riley Conference

Select Energy Services (NYSE: WTTR) is a provider of total water management solutions and also a developer and manufacturer of chemical solutions to the North American unconventional oil and gas industry. Select provides for the sourcing and transfer of water, both by permanent pipeline and temporary hose, prior to its use in the drilling and completion activities associated with hydraulic fracturing, as well as complementary water-related services that support oil and gas well completion and production activities. Select currently provides services to exploration and production companies and oilfield service companies operating in all the major shale and producing basins in…

ThursdayMay 23, 2019 6:30 pm

Energous Corp. (WATT) Starts Presentation at B. Riley Conference

Energous (NASDAQ: WATT) is leading the next generation of wireless charging with its award-winning WattUp technology, which supports fast, efficient contact-based charging, as well as charging over-the-air. WattUp is a scalable, RF-based wireless charging technology that offers substantial improvements in contact-based charging efficiency, foreign object detection, orientation freedom and thermal performance. The technology can be designed into many different sized electronic devices for home and office, as well as the medical, industrial, retail and automotive industries, ensuring interoperability across products. For more information, visit the company's website at www.Energous.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution…

ThursdayMay 23, 2019 6:30 pm

TrueCar Inc. (TRUE) Starts Presentation at B. Riley Conference

TrueCar (NASDAQ: TRUE) is a digital automotive marketplace that provides comprehensive pricing transparency about what other people paid for their cars and enables consumers to engage with TrueCar Certified Dealers who are committed to providing a superior purchase experience. TrueCar operates its own branded site and its nationwide network of more than 16,000 Certified Dealers also powers car-buying programs for some of the largest U.S. membership and service organizations, including USAA, AARP, American Express, AAA and Sam's Club. Over half of all new car buyers engage with the TrueCar network during their purchasing process. For more information, visit the company's…

ThursdayMay 23, 2019 6:30 pm

Vishay Precision Group Inc. (VPG) Starts Presentation at B. Riley Conference

Vishay Precision Group (NYSE: VPG) is an internationally recognized designer, manufacturer and marketer of components based on its resistive foil technology; sensors; and sensor-based measurement systems specializing in the growing markets of stress, force, weight, pressure and current measurements. VPG is a market leader of foil technology products, providing ongoing technology innovations in precision foil resistors and foil strain gages, which are the foundation of the company’s force sensors products and its weighing and control systems. The product portfolio consists of a variety of well-established brand names recognized for precision and quality in the marketplace. For more information, visit the…